1 / 69

Liver and Renal Disease in Pregnancy

Liver and Renal Disease in Pregnancy. Physiological changes. Pregnancy is associated with increased liver metabolism ↓ Protein concentrations (20-40 % fall in albumin due to hemodylution) ↑ fibrynogen, celuroplasmin, transferrin, TBG (thyroid BG), CBG(corticosteroid BG) ↔ Bilirubin

ata
Download Presentation

Liver and Renal Disease in Pregnancy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Liver and Renal Disease in Pregnancy

  2. Physiological changes • Pregnancy is associated with increased liver metabolism • ↓Protein concentrations (20-40 % fall in albumin due to hemodylution) • ↑fibrynogen, celuroplasmin, transferrin, TBG (thyroid BG), CBG(corticosteroid BG) • ↔Bilirubin • ↑Alkaline phosphatase ( due to placental production) upper limit in third trimester - 400 U/l • ↓fall in upper limit for AlAT, AspAT, SGOT

  3. Liver Disease • Hyperemesis gravidarum • Cholestasis garvidarum • Acute fatty liver of pregnancy • HELLP syndrome • Viral hepatitis • Pre-existing liver disease • Gall bladder disease

  4. Approach to Liver Disease in Pregnancy • Liver disease occurs in approximately 3% of deliveries • There are liver diseases which are specific to pregnancy • Hyperemesis gravidarum • Intrahepatic cholestasis of pregnancy • Acute fatty liver of pregnancy • HELLP syndrome • Liver dysfunction may also be seen in patients with hepatitis

  5. Hyperemesis gravidarum • Severe vomiting in early pregnancy • Occurse in 0,1 –1% of pregnancies („Normal” nausea and vomiting are very common, up to 50% of pregnancies) • causing fluid, electrolyte and nutritional disturbance • May be associated with abnormal liver function in up to 50% cases

  6. Hyperemesis gravidarum Clinical manifestation: • Vomiting up to 20 times a day, vamiting after eating, drinkig water, brushing teeth, spontaniously. Impossible to swallow saliva. Fatigue, fainting, weight loss, muscle wasting, • Dehydratation with hypotension and tachycardia Laboratory tests: • Hyponatremia, hypocaliemia, low serum urea, metabolic hypochloremic alkalosis, ketonuria, rised haematocrit, rised gravity of urine • Abnormal thyroid tests: ⇑FT 3 , FT4, ⇓ TSH( up to 66% cases) Patient is clinically euthyreoid, no antithyroid antibodies, no need for drugs, resolves as hyperemesis improves. • a moderate rise in transaminases ( 50 – 200U/l), slightly rised bilirubin, jaundice is uncommon

  7. Hyperemesis gravidarum • Pathophysiology is poorly understood • Severity of hyperemesis is conected with hyperthyroidism • Level of hCG ( whitch shares £ - subunit with TSH) is conected with severity of vomiting • Increased incidence of hyperemeis in multiple pregnancy and hydatidiform mole (⇑hCG) • Psychological and behavioural thories • Usually there is rapid improvement on admission to hospital • Recurse in subsequent pegnacies

  8. Hyperemesis gravidarum Maternal complications: • Vitamin deficiencies ( B1 – thiamine – Wernicke`s encephalopathy, B6 - pirydoxine and B12- cyanocobalamin – anaemia and perpheral neuropathy • Malnutrition • Mallory- Weiss tears of oesophagus • Severe hyponatremia cousing seisures, lethargy, respiratory arrest • Psychological problems (request for termiantion of pregnancy) • thrombosis

  9. Hyperemesis gravidarum Fetal complications: • Feal death up to 40% associated with Wernicke`s encephalopathy • Lower birthweight

  10. Hyperemesis gravidarum Treatment: • 0,9% NaCl (150 mmol/L Na), Hartmann solution ( 130mmol/L Na) • 30 - 40 mmol /L Potassium chloride • Enteral feeding / Total parenteral nutrition • Thiamine supplementation • Antiemetics: dopamine antagonist: metoclopramide, H1 receptor antagonist: promethasine - Diphergan, phenothiazines: Torecan • Corticosteroids – prednisolone 40-50 mg /d poor hydrocortisone 100 mg iv

  11. Acute Fatty Liver in Pregnancy

  12. Acute Fatty Liver of Pregnancy • Affects 1 in 10000 – 13000 pregnancies • maternal mortality of 10% • fetal mortality up to 45% • improved outcomes have been attributed to early recognition of the disorder followed by prompt delivery • association with nulliparity, twin gestations, male fetus and pre-eclampsia or eclampsia

  13. Etiology • Remains unknown • These diseases are characterized by microvesicular fatty infiltration of hepatocytes without inflammation or necrosis

  14. Clinical Manifestations • Generally occurs in the second half of pregnancy • Mean gestational age > 30 week

  15. Clinical Manifestations • The duration of prodromal symptoms and signs is variable • Often presents with nausea and vomiting, followed by severe abdominal pain and headache

  16. Clinical Manifestations • The right upper quadrant is generally tender, but the liver is not enlarged to palpation • Within a few days, jaundice appears, and the patient becomes somnolent and eventually comatose • Hematemesis and spontaneous bleeding result when the patient develops hypoprothrombinemia and DIC

  17. Clinical Manifestations • Oliguria, metabolic acidosis, and eventually anuria occur in approximately 50 percent of patients • Diabetes insipidus may also accompany the disease, but may not manifest itself until postpartum

  18. Clinical Manifestations • If the disease is allowed to progress, labor begins and the patient delivers a stillborn infant • Uteroplacental insufficiency may be the cause of fetal distress and fetal death in these patients.

  19. Clinical Manifestations • During the immediate postpartum period, the mother becomes febrile, comatose and, without therapy, dies within a few days • DIC, renal failure, profound hypoglycemia, and occasionally pancreatitis are the most often cited immediate causes of death

  20. Lab Investigations • Serum transaminases • elevated, but usually below 400 IU/L • ALP increases • Coagulation factors • INR increases before PTT because of vitamin K dependent clotting factors made in the liver • fibrinogen decreases, D-dimer increases with DIC • Bilirubin • mildly elevated

  21. Lab Investigations • Serum ammonia - elevated • Serum glucose - decreased

  22. Further Investigations • Liver Biopsy • liver biopsy not advised for diagnosis in most cases due to coagulopathy • pericentral microvesicular fatty change • minimal inflammatory cell infiltration or hepatic necrosis • periportal areas are usually preserved

  23. Histology

  24. Management • Once diagnosis is made, delivery should be carried out as soon as possible • Need to ensure patient is stable • Vaginal delivery is preferable • C/S can be performed if it appears vaginal delivery cannot be carried out in a timely fashion or if patient is deteriorating

  25. Management • If delivery is carried out before hepatic encephalopathy and renal failure develop, patients recover rapidly • No long- term liver damage

  26. Recurrence Risk • Little risk of recurrence in subsequent pregnancies

  27. Intrahepatic Cholestasis of Pregnancy

  28. Background • Incidence of 1 in 750-7,000 pregnancies • Uneven incidence worldwide • High incidence in Chile and Sweden • Seems to have a seasonal variation, peaking in November • association with twin gestations, old mothers, HCV infection

  29. Pathogenesis • Cause is unknown • Evidence suggests both genetic and hormonal factors play a role • Decresed bile acides transport to bile (in hepatocite)

  30. Clinical Manifestations • Generally occurs in second and third trimesters • Usually begins with pruritis at night • Pruritis is often generalized, but predominates on palms and soles of feet • Progresses to continuous pruritis

  31. Clinical Manifestations • May have excoriations due to scratching • Abdominal pain is uncommon • Occasionally may have dark urine and pale stool

  32. Clinical Manifestations • ~2 weeks after start of symptoms, jaundice develop in 50% • Accounts for 20-25% of cases of jaundice during pregnancy • Jaundice is usually mild, but persists until delivery • Symptoms usually abate about 2 days after delivery

  33. cholestasis xerosis (dry skin) medications uremia iron deficiency leukemia HIV polycythemia lymphoma thyroid disorders diabetes visceral malignancies multiple sclerosis Differential Diagnosis for pruritis without a primary skin lesion

  34. Lab Investigations • ALP • increases 5-10 fold • Serum total bile acids • may increase to more then 10x normal • Total bilirubin • mildly increased • AST, ALT • may increase - 200IU/L

  35. Lab Investigations • GGT • normal or slightly elevated • Coagulation factors • INR • usually normal • may be increased scondary to Vitamin K deficiency due to cholestasis or due to the use of bile acid sequestrants

  36. Diagnosis • Fasting serum bile acids must be more then 3 times the upper limit of normal • Clinical symptoms must also be present for diagnosis • Need to exclude other causes of jaundice and pruritus including viral hepatitis, primary biliary cirrhosis and biliary tract disease

  37. Diagnosis • Ultrasound • reveals no biliary duct dilation, hepatic parenchyma appear normal • Liver Biopsy • rarely necessary for diagnosis • histologically shows: • centrilobular areas reveal dilated bile canaliculi • these changes tend to regress after pregnancy

  38. Management • Cholestyramine • anion binding resin that interrupts the enterohepatic circulation, reducing reabsorption of bile acids • dose 8-28 g/day in three to four divided doses • may take up to 2 weeks to work, so should start as soon as pruritis is noted • check INR qweekly, as affects vitamin K absorption • may cause bloating and constipation, poorly tolerated • Intracranial heamorhage of the fetus??

  39. Management • Ursodeoxycholic acid (UDCA) • Endogenous hydrophilic bile acid, reduces the proportion of hydrophobic = hepatotoxic bile acid,increases bile flow • causes significant decrease in pruritus and decrease liver function studies, decrease in total bile acid • dose 500 -1500mg per day • Fenobarbital • Induction of liver enzymes • Increase bile acides secreatio to bile • dose 60 mg / for night

  40. Management • Dexametazon • prodiction of estrogens • decrease liver function studies • dose 12 mg/ per day – for 10 days • Antihistamines may help on reducing symptoms • Vit. K (10 mg/ d orally)

  41. Management • Delivery • In most cases, delivery should be accomplished by 38 weeks • If cholestasis is severe, delivery should be considered at 36 weeks if fetal lung maturity is documented

  42. Outcomes • Perinatal Outcome • Main complications are prematurity, meconuim-stained amniotic fluid and intrauterine demise • Probability of fetal complications is directly related to bile acid levels

  43. Outcomes • Perinatal Outcome • Antepartum FHR testing and fetal surveillance should be undertaken • May induce labour at term, or when amniotic fluid studies indicate oligohydramnios

  44. Outcomes • Maternal Outcome • Maternal prognosis is good • Pruritis usually begins to resolve around 2 days postpartum • There are generally no hepatic sequelae • Recurs in 60-70% of subsequent pregnancies • Recurrent episodes are variable in severity

  45. Outcomes • Maternal Outcome • May be at increased risk for gallstones • OCP – administration rarely results in recurrent cholestasis

  46. Differential Diagnosis • When patients present with signs of liver disease, appropriate workup needs to be undertaken to determine the cause • Generally a combination of clinical manifestations and lab results can help diagnose a patient • Rarely is invasive testing ie. liver biopsy necessary for diagnosis

  47. Differential Diagnosis of Liver Disease in Pregnancy

  48. Gall bladder disease • Gallsotnes are found in 8 % of nulliparus women and in 20 % of pluriparus women • ⇑risk: obesity, > 35 years of age • Gallsotne noeformation was documented in 3 – 8% of pregnant women • Acute cholecistitis occures in 0,1 % pregnancies • ⇑formation of cholesterol gallstones (estrogen related increased cholesterol saturation of bile and the rate of secretion of cholesterol), impaired gall bladder contractility leading to gall bladder stasis • Gall bladder disease are second common non-obstetrical couse of abdominal operations

  49. Gall bladder disease Clinical manifestations of biliary colic: • Similar to non- pregnant • Pain in right upper quadrant of epigastrum, may radioate to the back and scapula • Nusea, vomiting and indigestion Clinical manifestations of aute cholecistitis: • More severe pain • High fever, shivers

  50. Gall bladder disease Diagnosis: • Ultrasound – detection of gallstones, pericholecystis fluid, distention and thickening of gall bladder wall, ulrasound transduser- indused pain over gall bladder • aute cholecistitis - ⇧WBC, Abnormal liver function tests. Complications: • Jaundice • pancreatitis

More Related